GARY L CLAYMAN
Medical Practice at Doliver Dr, Houston, TX
License number
Florida 125739
Issued Date
Sep 30, 2015
Effective Date
Sep 30, 2015
Expiration Date
Jan 31, 2018
Category
Health Care
Type
Medical Doctor
Address
Address
2
5537 Doliver Dr, Houston, TX 77056
2400 Cypress Glen Dr, Zephyrhills, FL 33544
2400 Cypress Glen Dr, Zephyrhills, FL 33544
Phone
(281) 300-4334
Personal information
See more information about GARY L CLAYMAN at radaris.comName
Address
Phone
2305 Lucaya Ln APT B3, Coconut Creek, FL 33066
6680 NW 76Th Ct, Parkland, FL 33067
6353 Westchester St, Houston, TX 77005
1515 Holcombe Blvd, Houston, TX 77030
5005 Hidalgo St, Houston, TX 77056
Professional information
Dr. Gary L Clayman - MD (Doctor of Medicine)
Hospitals:
1515 Holcombe Blvd, Houston 77030
MD Anderson Cncr Ctr Hd Nck Sgy
1515 Holcombe Blvd SUITE 1445, Houston 77030
1515 Holcombe Blvd, Houston 77030
MD Anderson Cncr Ctr Hd Nck Sgy
1515 Holcombe Blvd SUITE 1445, Houston 77030
MD Anderson Cncr Ctr Hd Nck Sgy
1515 Holcombe Blvd SUITE 1445, Houston 77030
1515 Holcombe Blvd, Houston 77030
MD Anderson Cncr Ctr Hd Nck Sgy
1515 Holcombe Blvd SUITE 1445, Houston 77030
Education:
Medical Schools
Northeastern Oh Univs Coll Of Med
Graduated: 1986
Northeastern Oh Univs Coll Of Med
Graduated: 1986
Gary Lee Clayman, Houston TX
Specialties:
Ear, Nose & Throat Doctor
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Northeastern Ohio Universities, College of Medicine - Doctor of Medicine
University of MN Medical Center-Riverside Campus - Residency - Otolaryngology
University of MN Medical Center-Riverside Campus - Residency - Otolaryngology
Board certifications:
American Board of Otolaryngology Certification in Otolaryngology
Isolation Of A Cell-Specific Internalizing Peptide That Infiltrates Tumor Tissue For Targeted Drug Delivery
US Patent:
2006018, Aug 24, 2006
Filed:
Feb 8, 2005
Appl. No.:
11/053602
Inventors:
Frank Hong - Houston TX, US
Gary Clayman - Houston TX, US
Gary Clayman - Houston TX, US
International Classification:
A61K 51/00, C12Q 1/68, A61K 49/10, C07K 14/82, A61K 38/17
US Classification:
424001110, 514012000, 435006000, 530350000, 424009600, 424009360
Abstract:
The present invention provides a tumor-homing peptide that can target cancer and or tumor tissues. The peptide is uptaken by certain specific cancer cell types. The invention describes methods to achieve targeted delivery of anticancer drugs conjugated to this peptide for anticancer therapy. The invention also describes methods for using the peptide for the diagnosis and imaging of cancer and tumor tissues.
Methods And Compositions For The Diagnosis And Treatment Of Cancer
US Patent:
2006003, Feb 16, 2006
Filed:
Aug 9, 2005
Appl. No.:
11/200527
Inventors:
Gary Clayman - Houston TX, US
International Classification:
A61K 48/00
US Classification:
514044000
Abstract:
Methods for the treatment of squamous cell carcinoma using a p53-expressing viral vector are disclosed. In particular embodiments, the vector is a replication-deficient adenovirus. In addition, there are provided methods for examining the development and treatment of microscopic residual disease in the context of post-surgical environments and in body cavities.
Methods And Compositions Of A Novel Serine Protease Inhibitor
US Patent:
2004018, Sep 16, 2004
Filed:
Jan 28, 2004
Appl. No.:
10/766778
Inventors:
Gary Clayman - Houston TX, US
Torahiko Nakashima - Fukuoka City, JP
Paul Spring - Lexington KY, US
Torahiko Nakashima - Fukuoka City, JP
Paul Spring - Lexington KY, US
Assignee:
Board of Regents, The University of Texas System
International Classification:
C12Q001/68, C07H021/04, C12N009/99, C07K016/40
US Classification:
435/006000, 435/069200, 435/184000, 435/320100, 435/325000, 530/388260, 536/023200
Abstract:
The present invention describes a novel gene encoding a novel protein termed headpin (for head and neck serpin) that is homologous to known serine protease inhibitors. The invention describes methods and compositions of the nucleic acids, encoded proteins, antibodies, pharmaceuticals, cancer treatments, diagnostics and screens for modulators of headpin.
Methods And Compositions For The Diagnosis And Treatment Of Cancer
US Patent:
2003016, Sep 4, 2003
Filed:
Mar 24, 2003
Appl. No.:
10/395864
Inventors:
Gary Clayman - Houston TX, US
Assignee:
Board of Regents, The University of Texas System
International Classification:
A61K048/00, C12N015/861, C12N015/867
US Classification:
514/044000, 424/093200, 435/456000
Abstract:
Methods for the treatment of squamous cell carcinoma using a p53-expressing viral vector are disclosed. In particular embodiments, the vector is a replication-deficient adenovirus. In addition, there are provided methods for examining the development and treatment of microscopic residual disease in the context of post-surgical environments and in body cavities.
Isolation Of A Cell-Specific Internalizing Peptide That Infiltrates Tumor Tissue For Targeted Drug Delivery
US Patent:
2002010, Aug 1, 2002
Filed:
Jul 2, 2001
Appl. No.:
09/899376
Inventors:
Frank Hong - Houston TX, US
Gary Clayman - Houston TX, US
Gary Clayman - Houston TX, US
International Classification:
A61K048/00, A61K051/00, C07H021/04, A61K039/395, C07K016/46
US Classification:
424/178100, 424/093210, 514/044000, 435/069100, 435/326000, 435/320100, 530/389100, 536/023500, 424/001490
Abstract:
The present invention provides a tumor-homing peptide that can target cancer and or tumor tissues. The peptide is uptaken by certain specific cancer cell types. The invention describes methods to achieve targeted delivery of anticancer drugs conjugated to this peptide for anticancer therapy. The invention also describes methods for using the peptide for the diagnosis and imaging of cancer and tumor tissues.
Methods And Compositions For The Diagnosis And Treatment Of Cancer
US Patent:
2002007, Jun 20, 2002
Filed:
Oct 1, 2001
Appl. No.:
09/968958
Inventors:
Gary Clayman - Houston TX, US
Assignee:
Board of Regents, The University of Texas System
International Classification:
A61K048/00, C12N015/861
US Classification:
514/044000, 424/093210, 435/320100
Abstract:
Methods for the treatment of squamous cell carcinoma using a p53-expressing viral vector are disclosed. In particular embodiments, the vector is a replication-deficient adenovirus. In addition, there are provided methods for examining the development and treatment of microscopic residual disease in the context of post-surgical environments and in body cavities.